Cargando…
Thiamine as a metabolic resuscitator in septic shock: a randomized, double-blind, placebo-controlled, pilot trial
Autores principales: | Donnino, M, Andersen, LW, Chase, M, Berg, KM, Giberson, TA, Smithline, H, Tidswell, M, Wolfe, R, Cocchi, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471244/ http://dx.doi.org/10.1186/cc14472 |
Ejemplares similares
-
Corticosteroid therapy in refractory shock following cardiac arrest: a randomized, double-blind, placebo-controlled, trial
por: Donnino, Michael W., et al.
Publicado: (2016) -
Ubiquinol (reduced Coenzyme Q10) in patients with severe sepsis or septic shock: a randomized, double-blind, placebo-controlled, pilot trial
por: Donnino, Michael W., et al.
Publicado: (2015) -
Thiamine as an adjunctive therapy in cardiac surgery: a randomized, double-blind, placebo-controlled, phase II trial
por: Andersen, Lars W., et al.
Publicado: (2016) -
Pharmacokinetics of high-dose oral thiamine hydrochloride in healthy subjects
por: Smithline, Howard A, et al.
Publicado: (2012) -
Effect of Ascorbic Acid, Corticosteroids, and Thiamine on Health-Related Quality of Life in Sepsis
por: Grossestreuer, Anne V., et al.
Publicado: (2020)